title: The structural basis of the inhibition of human glycosidases by castanospermine analogues.
abstract: A series of epimers and deoxy derivatives of castanospermine has been synthesized to investigate the contribution of the different chiral centres to the specificity and potency of inhibition of human liver glycosidases. Castanospermine inhibits all forms of alpha- and beta-D-glucosidases, but alteration to any of the five chiral centres in castanospermine markedly decreases the inhibition. 6-Epicastanospermine, which is related to D-pyranomannose in the same way as castanospermine is to D-pyranoglucose, does not inhibit lysosomal (acidic) alpha-mannosidase, but is a good inhibitor of the cytosolic or neutral alpha-mannosidase. Conversely, 1-deoxy-6-epicastanospermine inhibits acidic alpha-mannosidase strongly, but not the neutral alpha-mannosidase. An explanation of this different inhibition based on preferential recognition of different configurations of mannose by the different forms of alpha-mannosidase is postulated. All derivatives of 6-epicastanospermine also have the minimum structural feature for the inhibition of alpha-L-fucosidase, but those with a beta-anomeric substituent do not inhibit the enzyme, or do so very weakly. 1-Deoxy-6,8a-diepicastanospermine, which has four chiral centres identical with alpha-L-fucose, is, however, a potent inhibitor of alpha-L-fucosidase (Ki 1.3 microM).
authors.affiliation: Department of Clinical Biochemistry, Institute of Child Health, University of London, U.K.
authors.forename: B G
authors.initials: BG
authors.lastname: Winchester
authors.forename: I
authors.initials: I
authors.lastname: Cenci di Bello
authors.forename: A C
authors.initials: AC
authors.lastname: Richardson
authors.forename: R J
authors.initials: RJ
authors.lastname: Nash
authors.forename: L E
authors.initials: LE
authors.lastname: Fellows
authors.forename: N G
authors.initials: NG
authors.lastname: Ramsden
authors.forename: G
authors.initials: G
authors.lastname: Fleet
mesh_terms: D000470:Alkaloids / Q000494:pharmacology*; D003600:Cytosol / Q000201:enzymology; D065089:Glycoside Hydrolase Inhibitors; D006026:Glycoside Hydrolases / Q000037:antagonists & inhibitors*; D006801:Humans; D007212:Indolizines; D008099:Liver / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D008361:Mannosidases / Q000037:antagonists & inhibitors; D015394:Molecular Structure; D013329:Structure-Activity Relationship; D005644:alpha-L-Fucosidase / Q000037:antagonists & inhibitors; D043323:alpha-Mannosidase; D001617:beta-Glucosidase / Q000037:antagonists & inhibitors; D054836:Indolizidines
chemical_list: D000470:Alkaloids; D065089:Glycoside Hydrolase Inhibitors; D006026:Glycoside Hydrolases; D007212:Indolizines; D008361:Mannosidases; D005644:alpha-L-Fucosidase; D043323:alpha-Mannosidase; D001617:beta-Glucosidase; C037806:castanospermine; D054836:Indolizidines